×
About 29,018 results

ALLMedicine™ Radical Prostatectomy Center

Research & Reviews  13,885 results

MiRNAs and radical prostatectomy: current data, bioinformatic analysis, and utility as ...
https://doi.org/10.1111/andr.12994
Andrology Konoshenko MY, Laktionov PP

Feb 27th, 2021 - Studies of microRNAs (miRNAs) and genes have particular interest for cancer biology and medicine due to the discovery of new therapeutic targets and markers. These studies are extensively influenced by anticancer therapy, as miRNAs interfere with ...

In vivo imaging of methionine aminopeptidase II for prostate cancer risk stratification.
https://doi.org/10.1158/0008-5472.CAN-20-2969
Cancer Research; Xie J, Rice MA et. al.

Feb 27th, 2021 - Prostate cancer is one of the most common malignancies worldwide, yet limited tools exist for prognostic risk stratification of the disease. Identification of new biomarkers representing intrinsic features of malignant transformation and developme...

A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate-Specif...
https://doi.org/10.1097/JU.0000000000001698
The Journal of Urology; Pienta KJ, Gorin MA et. al.

Feb 26th, 2021 - PSMA-targeted PET/CT has the potential to improve the detection and localization of prostate cancer (PCa). OSPREY was a prospective trial designed to determine the diagnostic performance of 18F-DCFPyL-PET/CT for detecting sites of metastatic PCa. ...

Health-related quality of life and self-reported cognitive function in patients with de...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7908756
Health and Quality of Life Outcomes; Kahl U, Callsen S et. al.

Feb 26th, 2021 - Delayed neurocognitive recovery (DNCR) is a common and serious complication after radical prostatectomy. We hypothesized that patients with DNCR in the early postoperative period would report reduced health-related quality of life (HRQoL) and more...

see more →

Guidelines  29 results

Rana R. McKay, MD, on Prostate Cancer: Intense Androgen-Deprivation Therapy Before Radical Prostatectomy
https://ascopost.com/videos/asco20-virtual-scientific-program/rana-mckay-on-intense-adt-before-radical-prostatectomy/

May 31st, 2020 - Rana R. McKay, MD, of the University of California, San Diego, discusses the results of a phase II trial of intense neoadjuvant hormone therapy followed by radical prostatectomy in men with high-risk prostate cancer. The data show that 21% of pati...

Adjuvant and Salvage Radiotherapy after Prostatectomy: ASTRO/AUA Guideline
https://www.auanet.org/guidelines/prostate-cancer-adjuvant-and-salvage-radiotherapy-guideline
Thompson,I.,et al

Apr 29th, 2019 - The purpose of this guideline is to provide direction to clinicians and patients regarding the use of radiotherapy after radical prostatectomy in the adjuvant or salvage setting. The strategies and approaches recommended in the guideline were deri...

Use of Active Surveillance or Watchful Waiting for Low-Risk Prostate Cancer and Management Trends Across Risk Groups in the United States, 2010-2015
https://jamanetwork.com/journals/jama/fullarticle/2724897?resultClick=1
Mahal,B.,et al

Feb 10th, 2019 - Historically, most patients with low-risk prostate cancer (clinical category T1c-T2a, prostate-specific antigen level <10 ng/mL, and Gleason 6 disease) were treated with radical prostatectomy, while radiotherapy-based treatment was the favored app...

ACR Appropriateness Criteria® Post-treatment Follow-up Prostate Cancer.
https://doi.org/10.1016/j.jacr.2018.03.019
Journal of the American College of Radiology : JACR; , Froemming AT et. al.

May 4th, 2018 - Diagnosis and management of prostate cancer post treatment is a large and complex problem, and care of these patients requires multidisciplinary involvement of imaging, medical, and surgical specialties. Imaging capabilities for evaluation of men ...

Brachytherapy for Patients With Prostate Cancer
http://ascopubs.org/doi/full/10.1200/JCO.2016.72.0466
Joseph Chin

May 19th, 2017 - For patients with low-risk prostate cancer who require or choose active treatment, low–dose rate brachytherapy (LDR) alone, EBRT alone, and/or radical prostatectomy (RP) should be offered to eligible patients. For patients with intermediate-risk p.

see more →

Clinicaltrials.gov  14,509 results

MiRNAs and radical prostatectomy: current data, bioinformatic analysis, and utility as ...
https://doi.org/10.1111/andr.12994
Andrology Konoshenko MY, Laktionov PP

Feb 27th, 2021 - Studies of microRNAs (miRNAs) and genes have particular interest for cancer biology and medicine due to the discovery of new therapeutic targets and markers. These studies are extensively influenced by anticancer therapy, as miRNAs interfere with ...

In vivo imaging of methionine aminopeptidase II for prostate cancer risk stratification.
https://doi.org/10.1158/0008-5472.CAN-20-2969
Cancer Research; Xie J, Rice MA et. al.

Feb 27th, 2021 - Prostate cancer is one of the most common malignancies worldwide, yet limited tools exist for prognostic risk stratification of the disease. Identification of new biomarkers representing intrinsic features of malignant transformation and developme...

A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate-Specif...
https://doi.org/10.1097/JU.0000000000001698
The Journal of Urology; Pienta KJ, Gorin MA et. al.

Feb 26th, 2021 - PSMA-targeted PET/CT has the potential to improve the detection and localization of prostate cancer (PCa). OSPREY was a prospective trial designed to determine the diagnostic performance of 18F-DCFPyL-PET/CT for detecting sites of metastatic PCa. ...

Health-related quality of life and self-reported cognitive function in patients with de...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7908756
Health and Quality of Life Outcomes; Kahl U, Callsen S et. al.

Feb 26th, 2021 - Delayed neurocognitive recovery (DNCR) is a common and serious complication after radical prostatectomy. We hypothesized that patients with DNCR in the early postoperative period would report reduced health-related quality of life (HRQoL) and more...

see more →

News  595 results

22-Gene Classifier May Help Guide Decision Making After Radical Prostatectomy
https://www.medscape.com/viewarticle/946143

Feb 21st, 2021 - NEW YORK (Reuters Health) - The Decipher genomic classifier (GC) is a promising tool to help determine which men will benefit from hormone therapy in addition to salvage radiation after radical prostatectomy, researchers say. "These findings are t...

Postprostatectomy Urinary Outcomes Vary Widely by Patient and Surgeon
https://www.medscape.com/viewarticle/944813

Jan 27th, 2021 - (Reuters Health) - Patient-reported urinary outcomes three months after radical prostatectomy vary by patient and by surgeon, and a new study suggests that outcomes may be better with top-performing surgeons. Researchers examined data from the Mic...

Men With Localized Prostate Cancer Have Reduced Long-Term Quality of Life
https://www.staging.medscape.com/viewarticle/940015

Oct 29th, 2020 - NEW YORK (Reuters Health) - Men with localized prostate cancer, especially those who undergo radical prostatectomy, have generally worse long-term self-reported quality of life than men without a diagnosis of prostate cancer, according to new rese...

Men With Localized Prostate Cancer Have Reduced Long-Term Quality of Life
https://www.medscape.com/viewarticle/940015

Oct 29th, 2020 - NEW YORK (Reuters Health) - Men with localized prostate cancer, especially those who undergo radical prostatectomy, have generally worse long-term self-reported quality of life than men without a diagnosis of prostate cancer, according to new rese...

Hood Technique Can Facilitate Swift Return to Urinary Continence After Radical Prostatectomy
https://www.medscape.com/viewarticle/939789

Oct 26th, 2020 - NEW YORK (Reuters Health) - The "hood" technique for robot-assisted prostatectomy enabled a return to continence within four months, without compromising surgical margins, in a single-center, single-surgeon study. "The clinical findings show that ...

see more →